NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada

RTTNews | 1053 hari yang lalu
NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada

(RTTNews) - Biotechnology company NKGen Biotech Inc. (NKGN) announced Wednesday that it has received a No Objection Letter from Health Canada for its Clinical Trial Application for a Phase 1/2a study to evaluate the safety, tolerability, and exploratory efficacy of SNK01 natural killer cell therapy for the treatment of patients with moderate Alzheimer's Disease.

SNK01 program continues to show positive progress with the FDA IND clearance in October 2023, and now the CTA clearance by Health Canada. The U.S. Phase 1/2a trial of SNK01 in moderate Alzheimer's disease patients officially opened with first patient enrolled in December 2023.

This approved trial of approximately 36 patients with moderate AD is expected to commence in December 2023 with the first interim data expected in the third quarter of 2024.

Phase 1 is an open label safety evaluation to determine the maximum tolerated dose and/or recommended Phase 2 dose of SNK01.

Phase 2 is a randomized, placebo controlled, multicenter trial evaluating the safety and efficacy of SNK01 in moderate AD patients.

baca selengkapnya
U.S. Dollar Advances Amid Middle East Tensions, Tech Sector Slide

U.S. Dollar Advances Amid Middle East Tensions, Tech Sector Slide

The U.S. Dollar value moved higher on Friday after the U.S. and Iran adopted a tougher stance against any agreement and trounced expectations for a deal to end their conflict and reopen the Strait of Hormuz. In addition, the slide in the IT stocks due to Nvidia crisis weighed on the equity markets.
RTTNews | 20 jam 3 menit yang lalu
Swiss Market Ends On Weak Note

Swiss Market Ends On Weak Note

The Switzerland stock market ended modestly lower on Friday after languishing in negative territory throughout the trading session, as traders seemed reluctant to build up fresh positions amid a lack of positive news.
RTTNews | 23 jam 29 menit yang lalu
European Stocks End On Mixed Note After Cautious Session

European Stocks End On Mixed Note After Cautious Session

European stocks turned in a mixed performance on Friday as investors made cautious moves amid uncertainty over the outlook for the AI trade and possibility of a rate hike by the Federal Reserve in December. Optimism about corporate earnings aided sentiment a bit.
RTTNews | 1 hari yang lalu
U.S. Producer Prices Rise 0.3% In October, Slightly Less Than Expected

U.S. Producer Prices Rise 0.3% In October, Slightly Less Than Expected

A report released by the Labor Department on Friday showed producer prices in the U.S. increased by slightly less than expected in the month of October. The Labor Department said its producer price index for final demand rose by 0.3 percent in October after surging by an upwardly revised 1.4 percent in September. Economists had expected producer prices to climb by 0.4 percent.
RTTNews | 1 hari yang lalu
Bay Street Likely To Open On Mixed Note

Bay Street Likely To Open On Mixed Note

Canadian stocks look heaed for a mixed start Friday morning, tracking the trend in the commodities markets, and weighing the impact of Nvidia CEO Jensen Huang's resignation.
RTTNews | 1 hari yang lalu
Antipodean Currencies Fall Amid Risk-0ff Mood

Antipodean Currencies Fall Amid Risk-0ff Mood

The antipodean currencies such as the Australia and the New Zealand dollars weakened against other major currencies in the European session on Friday, as European shares dipped from record high amid uncertainty over the outlook for the AI trade and growing expectations for a Federal Reserve rate hike in December.
RTTNews | 1 hari yang lalu